LAUREN MILLER: Open Payments
NPI 1003042078 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$127,145 in 230 payments from 19 companies in 2025. Trend: 2023 $144,322 · 2024 $116,310 · 2025 $127,145
Speaker / faculty: $87,336Travel & lodging: $16,496Consulting: $11,087Honoraria: $6,650Food & beverage: $5,576
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 42 | $25,364 |
| Amgen Inc. | 42 | $25,319 |
| GENZYME CORPORATION | 18 | $15,165 |
| Lilly USA, LLC | 19 | $13,679 |
| Regeneron Healthcare Solutions, Inc. | 11 | $11,432 |
| ABBVIE INC. | 33 | $10,146 |
| Organon LLC | 23 | $9,089 |
| PFIZER INC. | 8 | $4,929 |
| Eli Lilly and Company | 3 | $4,829 |
| E.R. Squibb & Sons, L.L.C. | 8 | $4,201 |
Products named: DUPIXENT, Bimzelx, EBGLYSS, RINVOQ, VTAMA, CIBINQO, Sotyktu, OTEZLA.
Industry payments across AL — which companies pay providers there.
